RecruitingNCT07113808

Pediatric Intravenous Contrast-Enhanced Ultrasound(CEUS) in China

Clinical Medical Quality Control Management of Pediatric Intravenous Contrast-Enhanced Ultrasound(CEUS) in China: A Multi-Center Study


Sponsor

The Children's Hospital of Zhejiang University School of Medicine

Enrollment

108 participants

Start Date

Sep 10, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

The goal of this clinical trial is to evaluate the application of intravenous contrast-enhanced ultrasound examination in children with intra-abdominal diseases that require clear diagnoses. The main questions it aims to answer are: * Is intravenous contrast-enhanced ultrasound helpful for the diagnosis of intra-abdominal diseases in children? * What medical problems do participants have when participating in intravenous contrast-enhanced ultrasound examination? * How can ultrasound doctors conduct intravenous contrast-enhanced ultrasound examinations in a standardized manner? Researchers will performing intravenous contrast-enhanced ultrasound examinations on participants and collecting research subjects to establish a multicenter clinical data database. Participants will: * Perform abdominal ultrasound examination to assess the condition. * At least conduct one intravenous contrast-enhanced ultrasound examination. Based on the result of the contrast examination, decide whether to conduct another examination. * Keep a diary of their symptoms and therapeutic process in 30 days.


Eligibility

Min Age: 29 DaysMax Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called SonoVue® and a medical device called contrast-enhanced ultrasound examination for people with abdominal injury, abdominal neoplasm, and other related conditions. The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEcontrast-enhanced ultrasound examination

to evaluate the the application of contrast-enhanced ultrasound examination in children with intra-abdominal diseases that require clear diagnoses aged from 29 days to 18 years old

DRUGSonoVue®

perform contrast enhanced ultrasound (CEUS) using Sonovue as the contrast agent


Locations(1)

Children's Hospital, Zhejiang University School of Medicine

Hangzhou, Zhejiang, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07113808


Related Trials